Prevention of levarterenol sloughs; preliminary report.
D035843:Biomedical Research; D005734:Gangrene; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D009336:Necrosis / Q000209:etiology*; D009638:Norepinephrine / Q000009:adverse effects*; D012867:Skin; D013565:Sympatholytics / Q000627:therapeutic use*
D013565:Sympatholytics; D006821:Hyaluronoglucosaminidase; D009638:Norepinephrine
ARTERENOL/injurious effects; HYALURONIDASE/therapeutic use; NECROSIS/etiology and pathogenesis; SKIN/gangrene; SYMPATHOLYTICS/therapeutic use